BACKGROUND Fractional flow reserve (FFR) invasively assesses the ischemic potential of coronary stenosis and predicts the expected improvement achievable by revascularization. A FFR value of 0.75 has been validated against ischemic testing, while a FFR value of 0.80 has been widely accepted to guide clinical decision making. Whether, and in which patients revascularization should be proposed when the FFR is between 0.76-0.80 "gray zone" is still debatable. Therefore, we studied the clinical outcome of patients with an isolated stenosis and an FFR value in and around the gray zone.
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METHODS From February 1997 to June 2013, all patients presenting with single segment disease at coronary angiography and FFR within the gray zone of 0.76-0.80 and in the neighbored strata of 0.70-0.75 and 0.81-0.85 were included. Patients with previous bypass surgery, in-stent restenosis, myocardial bridge, or heart transplantation were excluded. According to FFR values, patients were divided into the following strata: a) 0.70-0.75; b) 0.76-0.80; c) 0.81-0.85. Study endpoints consisted of major adverse cardiovascular events (MACE: death, myocardial infarction and any revascularization) up to 5 years. Data were also analyzed according to their lesion location (proximal versus distal).
RESULTS
Out of 17380 patients undergoing FFR measurement: a) overall FFR values were within the gray zone in 2781 (16%) of cases; b) 1459 fulfilled the inclusion/exclusion criteria and were included in the present analysis: 449 treated with revascularization (revasc) and 1010 with medical therapy (MT). Clinical characteristics were similar among patients treated with revascularization or MT, except for male gender and age (more frequent in PCI group respectively [p¼0.002] and [p¼0.05]). Diameter stenosis, minimum lumen diameter, and FFR values were lower in revasc group (p<0.0001). In patients with an FFR between 0.70 and 0.75, MACE's were more frequent after MT than after revasc (12 [23%] vs. 57 [13%], respectively, p¼0.046). In patients with an FFR between 0.81 and 0.85, MACE's were less frequent after MT than after revasc (59 [8%] vs. 57 [13%], respectively, p¼0.023). Among patients treated with MT alone, a progressive increase in MACE was observed in the 3 FFR strata (FFR, 0.70-0.75: 12 [23%] vs. FFR, 0.76-0.80: 37 [14%] vs. FFR, 0.81-0.85: 59 [8%], p<0.001). For stenoses located only in proximal segments, decreasing FFR values were parallelled by an increase MACE and in overall mortality (respectively p<0,001 and p¼0.017).
CONCLUSIONS Patients with stenosis located in the proximal coronary segments and FFR in the gray zone of 0.76-0.80 demonstrate a MACE rate that is intermediate compared with that of patients 0.75 ischemic threshold and above the 0.80 clinical threshold. These data suggest that an FFR 0.80 is valid to guide clinical decision making with lesion located in proximal coronary segments, while distal coronary stenosis with FFR in the gray zone might be safely deferred to MT.
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Quantification of the effect of measurement drift on the diagnostic performance of FFR, iFR and whole cycle Pd/Pa Christopher Cook, 1 Yousif Ahmad, 1 Sukhjinder S. Nijjer, 1 Matthew Shun-Shin, 2 Ricardo Petraco, 3 Rasha Al-Lamee, 4 Sayan Sen, 2 Justin E. Davies 2 1 Imperial College London, London, London; 2 Imperial College London, London, United Kingdom; 3 Imperial College, London, United Kingdom; 4 IMPERIAL COLLEGE NHS TRUST, London, London BACKGROUND Clinically tolerated levels of measurement drift (AE2mmHg) can affect the diagnostic accuracy of pressure-only indices of stenosis severity. This real world consideration has not formally been assessed for FFR, iFR and whole cycle Pd/Pa indices. The objective of this study was to quantify the effect of measurement drift on stenosis misclassification with FFR, iFR and whole cycle Pd/Pa indices.
METHODS Haemodynamic pressure traces from 447 stenoses (447 patients) were assessed with FFR, iFR and whole cycle Pd/Pa indices. Cut point values for significance were 0.8, <0.90 and <0.93 respectively. Measurement drift was simulated by offsetting the distal intracoronary pressure trace by AE2mmHg. FFR, iFR and whole cycle Pd/Pa indices were recalculated and the impact upon stenosis classification quantified.
RESULTS Median (AEmedian absolute deviation) values for FFR, iFR and whole cycle Pd/Pa medians were 0.81 (AE0.11), 0.90 (AE0.07), and 0.93 (AE0.06) respectively. The dynamic range of values for each index was different. iFR had the largest dynamic range of values (95% range: 0.39 -1.0, a 62 unit spread), compared to FFR (95% range: 0.43 -0.97, a 55 unit spread) and resting whole cycle Pd/Pa (95% range: 0.59 -1.0, a 41 unit spread) (p<0.001 for all comparisons). Stenosis misclassification occurred with all three indices. Both FFR and iFR had significantly lower proportions of misclassification than whole cycle Pd/Pa (p<0.001). There was no statistically significant difference between the diagnostic performance of FFR and iFR indices (p¼0.125). Overall, 21% (94), 25% (110) and 33% (148) of the total study population were inappropriately misclassified with FFR, iFR and whole cycle Pd/Pa respectively. 
